Skin Changes in Pediatric Transplant Patients

    October 2005 in “ Pediatric Transplantation ”
    Ana Paula Dornelles da Silva Manzoni, Ricardo Lapa Kruse, Carina Troian, Vanessa Cunha, Tânia Ferreira Cestari
    Image of study
    TLDR Pediatric transplant patients often experience unique skin changes mainly due to medication use.
    In 2003, a study in Porto Alegre, Brazil, followed 39 pediatric transplant patients, including 20 kidney, 11 bone marrow, and 8 liver recipients, up to 17 years old for six months post-transplant to observe skin changes. The study found that the most common skin changes were related to medication use, with an incidence density (ID) of 87.2, and kidney transplant patients had the highest ID for medication-related skin changes at 104.1. Bone marrow transplant recipients had the highest ID of skin appendage alterations at 85.4, while liver recipients had the highest ID of vascular changes at 94.9. Notable skin changes specific to pediatric patients included ichthyosiform xerosis in kidney recipients and skin scaling with a pellagroid appearance in bone marrow recipients. The study concluded that pediatric transplant recipients experience unique cutaneous alterations not seen in adults, primarily dermatoses secondary to medication use. The document also highlights the importance of preparing patients and families for potential cosmetic changes, the benefits of skin assessments before transplantation, and the need for education to manage these changes and improve quality of life.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 6 results

      community Topical finasteride now the safest possible path?

      in Finasteride/Dutasteride  82 upvotes 5 months ago
      Topical finasteride is considered a safer option for hair regrowth with fewer systemic side effects compared to oral finasteride. Some users report similar efficacy and side effects between topical and oral treatments, while others prefer topical due to reduced systemic exposure.

      community Dermatologist wants me to stop topical min+fin as a teen

      in Minoxidil  8 upvotes 1 year ago
      A 17-year-old has been using topical minoxidil and finasteride for hair loss but is advised by a dermatologist to taper off due to age concerns. Other users suggest continuing minoxidil but stopping finasteride until at least 18, and consulting a specialized pediatric dermatologist.

      community Diagnosed with MPB at 16 (Male)

      in Treatment  53 upvotes 7 months ago
      A 16-year-old diagnosed with male pattern baldness (MPB) was prescribed hair vitamins, vitamin D, a non-ketoconazole shampoo, and redenysl + serum, with a suggestion for GFC or IHRF treatments. Some users recommended minoxidil, ketoconazole, and derma stamping, while others advised against certain treatments until the age of 18.

      community [25, F] [RANT] Shedding since March 2020. This just isn’t fair.

      in Female  42 upvotes 3 years ago
      User "missbloombastic" has been experiencing hair loss since 2016 and tried min, fin, multivitamins, and spiro with mixed results. Another user shares their struggle with hair loss and its impact on self-esteem, while a third user suggests checking blood tests and confirming the cause of hair loss.

      community The MPB itch aka DHT itch is very real.

      in Chat  9 upvotes 1 year ago
      Hair loss itch is caused by DHT attacking follicles and stimulating nerves. Finasteride users who respond well don't experience this itch.

    Similar Research

    5 / 1000+ results